Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

Although there is strong evidence supporting the short-term efficacy and safety of anti-tumour necrosis factor-α agents, few studies have examined the long-term effects. We evaluated 511 patients with long-standing refractory rheumatoid arthritis treated with intravenous infusions of infliximab 3 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruyssen, Bert Vander, Van Looy, Stijn, Wyns, Bart, Westhovens, Rene, Durez, Patrick, Van den Bosch, Filip, Mielants, Herman, De Clerck, Luc, Peretz, Ann, Malaise, Michel, Verbruggen, Leon, Vastesaeger, Nathan, Geldhof, Anja, Boullart, Luc, De Keyser, Filip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779428/
https://www.ncbi.nlm.nih.gov/pubmed/16978395
http://dx.doi.org/10.1186/ar2001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779428/
https://www.ncbi.nlm.nih.gov/pubmed/16978395
http://dx.doi.org/10.1186/ar2001

Ejemplares similares